Corcept Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Corcept Therapeutics Inc
TickerCORT
CIK #0001088856
CUSIP218352102
SectorLife Sciences - Pharmaceutical Preparations
Address149 Commonwealth Drive, Menlo Park, CA 94025
Source [EDGAR]
CIK Filing 2011 - 2024
[0001088856] 10-K
[0001088856] 10-Q
[0001088856] 3
[0001088856] 4
[0001088856] 5
[0001088856] 8-K
[0001088856] D
[0001088856] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Corcept Therapeutics Inc [2023-01-20] 15.2
Baker G Leonard Jr Corcept Therapeutics Inc [2022-02-14] 5.2
Belanoff Joseph K Corcept Therapeutics Inc [2021-02-11] 5.3
Renaissance Technologies LLC Corcept Therapeutics Inc [2020-02-12] 6.8
Consonance Capital Management LP Corcept Therapeutics Inc [2018-02-14] 4.98
Vanguard Group Inc Corcept Therapeutics Inc [2018-02-08] 8.21
BlackRock Inc Corcept Therapeutics Inc [2017-01-30] 5.5
Form 3/4/5 Filer 2011 - 2024
Robb Gary Charles
Corcept Therapeutics Inc
Lyon Joseph Douglas
Maduck Sean
Mokari Atabak
Cannon Gillian
Wilson James N
Alton Gregg H
Baker G Leonard Jr
Mahoney David L
Swisher Daniel N JR
Park Kimberly
Murray Joshua M.
Guyer William
Belanoff Joseph K
Hunt Hazel
Grauer Andreas
Bradbury Daniel
Fishman Robert S
GALA Renee D
Enright Patrick G
Tammenoms Bakker Juliet
Longitude Capital Partners, LLC
Longitude Capital Associates, L.P.
Longitude Venture Partners L.P.
Lo Steven
LeDoux Anne M
Turner Joseph L
Cook Joseph C Jr
Gaither James C
Coxe Tench
Anderson David L
Younger William H Jr
Roe Robert L
Dyckerhoff Stefan A
Pullara Samuel J III
Sutter Hill Ventures
White James N
Sheehan Andrew T
Speiser Michael L
Bird Jeffrey W
Sweet David E
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 15,805,921.0 16,128,815.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 10,185,427.0
Ingalls & Snyder LLC [2023-03-31] OTR 110,381.0 8,370,017.0
Renaissance Technologies LLC [2023-03-31] SOLE 6,788,069.0 6,788,069.0
Parallel Advisors LLC [2023-03-31] SOLE 3,724,573.0 3,724,573.0
Novo Holdings A/S [2023-03-31] SOLE 3,377,768.0 3,377,768.0
Millennium Management LLC [2023-03-31] SOLE 2,435,152.0 3,300,152.0
State Street Corp [2023-03-31] DFND 3,009,564.0 3,290,905.0
Federated Hermes Inc [2023-03-31] DFND 2,760,296.0 2,760,296.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 1,904,505.0 2,017,111.0
Boston Trust Walden Corp [2023-03-31] DFND 1,593,839.0 1,919,179.0
Geode Capital Management LLC [2023-03-31] DFND 1,793,927.0 1,793,927.0
Northern Trust Corp [2023-03-31] DFND 353,082.0 1,297,218.0
Invesco Ltd. [2023-03-31] DFND 0.0 1,093,213.0
HSBC Holdings PLC [2023-03-31] DFND 972,315.0 972,315.0
Bank of America Corp /DE/ [2023-03-31] DFND 20,653.0 951,597.0
Bank of New York Mellon Corp [2023-03-31] DFND 853,574.0 891,047.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 889,963.0 889,963.0
Granite Investment Partners LLC [2023-03-31] SOLE 795,076.0 795,076.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 773,972.0 784,199.0
Morgan Stanley [2023-03-31] DFND 583,483.0 776,677.0
Shay Capital LLC [2023-03-31] SOLE 700,000.0 700,000.0
Man Group plc [2023-03-31] DFND 659,995.0 659,995.0
Principal Financial Group Inc [2023-03-31] DFND 586,259.0 586,259.0
Pacer Advisors Inc [2023-03-31] SOLE 11,253,583.0 519,556.0
AJ Wealth Strategies LLC [2023-03-31] SOLE 113,905.0 509,934.0
Aristeia Capital LLC [2023-03-31] SOLE 501,558.0 501,558.0
Goldman Sachs Group Inc [2023-03-31] DFND 394,126.0 403,431.0
Cambridge Investment Research Advisors Inc [2023-03-31] SOLE 0.0 366,220.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 362,778.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com